Related Experiment Video
Updated: Jun 16, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Identification of DBC1 as a transcriptional repressor for BRCA1
H Hiraike1, O Wada-Hiraike, S Nakagawa
1Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, Japan. osamu.hiraike@gmail.com
Background:
DBC1/KIAA1967 (deleted in breast cancer 1) is a putative tumour-suppressor gene cloned from a heterozygously deleted region in breast cancer specimens. Caspase-dependent processing of DBC1 promotes apoptosis, and depletion of endogenous DBC1 negatively regulates p53-dependent apoptosis through its specific inhibition of SIRT1. Hereditary breast and ovarian cancer susceptibility gene product BRCA1, by binding to the promoter region of SIRT1, is a positive regulator of SIRT1 expression.
Methods:
A physical interaction between DBC1 and BRCA1 was investigated both in vivo and in vitro. To determine the pathophysiological significance of DBC1, its role as a transcriptional factor was studied.
Results:
We found a physical interaction between the amino terminus of DBC1 and the carboxyl terminus of BRCA1, also known as the BRCT domain. Endogenous DBC1 and BRCA1 form a complex in the nucleus of intact cells, which is exported to the cytoplasm during ultraviolet-induced apoptosis. We also showed that the expression of DBC1 represses the transcriptional activation function of BRCT by a transient expression assay. The expression of DBC1 also inhibits the transactivation of the SIRT1 promoter mediated by full-length BRCA1.
Conclusion:
These results revealed that DBC1 may modulate the cellular functions of BRCA1 and have important implications in the understanding of carcinogenesis in breast tissue.
Insights
Deleted in breast cancer 1 (DBC1) interacts with BRCA1, modulating its function. This interaction impacts BRCA1
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- DBC1 (deleted in breast cancer 1) is a potential tumor suppressor gene.
- DBC1 influences apoptosis and p53-dependent pathways by inhibiting SIRT1.
- BRCA1 positively regulates SIRT1 expression.
Purpose of the Study:
- Investigate the physical interaction between DBC1 and BRCA1.
- Determine the functional significance of DBC1 in cellular processes.
Main Methods:
- In vivo and in vitro assays to confirm physical interaction.
- Transient expression assays to study transcriptional regulation.
- Analysis of protein complex localization during apoptosis.
Main Results:
- DBC1 physically interacts with the BRCT domain of BRCA1.
- DBC1 and BRCA1 form a nuclear complex that translocates to the cytoplasm during UV-induced apoptosis.
- DBC1 represses the transcriptional activation function of BRCA1 and inhibits SIRT1 promoter transactivation.
Conclusions:
- DBC1 modulates the cellular functions of BRCA1.
- Findings have implications for understanding breast cancer development.
Related Concept Videos
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
Restarting Stalled Replication Forks
Abnormal Proliferation

